Skip to main content
Darkfield

Ransomware victim disclosure

← All victims

吉林省药品监督管理局

listed as 吉林省药品监督管理局 (Jilin Provincial Drug Supervision and Administration Bureau) · Claimed by Pryx · listed 3 months ago

2m
Age
since listed · listed for ransom

Status timeline

  1. ListedJun 4, 2026

Current state: Listed for ransom

At a glance

Group
Pryx
Status
Listed for ransom
Country
China
Sector
Government/Healthcare Regulation
Listed on leak site
Jun 4, 2026

About the victim

AI dossier — public-source company profile

The Jilin Provincial Drug Supervision and Administration Bureau is a government agency under the Jilin Province administration responsible for drug and medical device regulation, approval, and supervision in the province. It operates the medical device registration and approval system and provides regulatory oversight for pharmaceutical and medical device manufacturers.

Industry
Government/Healthcare Regulation
Address
吉林省长春市经济技术开发区湛江路657号（仙台大街与湛江路交会处）

Attack summary

Severity: medium — Confirmed access to government regulatory agency systems and publication of internal administrative procedures. While not PII-at-scale or operational disruption to critical infrastructure, compromise of a healthcare regulatory body poses moderate risk to supply chain integrity and public health oversight. Single document published limits immediate severity but agency role is sensitive.

Pryx claims to have accessed and published an internal government document (notification on Class II Medical Device Registration Approval Process, dated 2026-03-25) from the Jilin Provincial Drug Supervision and Administration Bureau. The post lists the document without additional context regarding exfiltration scope or operational impact.

medium

Data the group says was taken

AI dossier — extracted from the leak post
  • Internal regulatory notifications
  • Medical device registration approval procedures
  • Government administrative documents

The group's post references roughly 1 proof file.

What the group claims

Notice regarding the registration and approval process for Class II medical devices, document number 吉药监械注册〔2026〕10号

The leak post

captured from the group's site
* [AG真人关于印发《第二类医疗器械注册审批流程》的通知 吉药监械注册〔2026...](https://www.pryx.cc/zxfw_84842/tzwj/202603/t20260325_9456045.html "AG真人关于印发《第二类医疗器械注册审批流程》的通知     吉药监械注册〔2026〕10 号")

Screenshot of the leak post

Leak screenshot for 吉林省药品监督管理局 (Jilin Provincial Drug Supervision and Administration Bureau)

Sources

Source

Indexed 3 months ago

This page surfaces a public ransomware disclosure indexed by Darkfield. Original posts come from the operator's own leak site; we cross-check against ransomware.live, RansomLook and RansomWatch where applicable. Share this URL freely.

Is this your supplier? Your competitor? You?

Pro plans monitor your domain, corporate emails, and crypto wallets across every new ransomware leak-site post, breach dump and Telegram callout — alerts within 5 minutes.

Disclosure context

About Pryx

Auto-discovered from ransomware tracking sources The group has been linked to 7 public disclosures across our corpus. First observed on a leak site on May 15, 2026; most recent post August 25, 2026. The operation is currently active.

Timeline of this disclosure

  • June 4, 2026吉林省药品监督管理局 (Jilin Provincial Drug Supervision and Administration Bureau) listed by Pryxon the group's public leak site

Other recent disclosures by Pryx

Pryx has been linked to 7 public victims on Darkfield. A sample of the most recent:

See the full Pryx dossier →

Sector and geography

This disclosure adds to ransomware activity in the Government/Healthcare Regulation sector. Geographically, 吉林省药品监督管理局 (Jilin Provincial Drug Supervision and Administration Bureau) is reported in China, a country with 45 ransomware disclosures in our corpus.

If your organisation is affected

A listing by Pryx means 吉林省药品监督管理局 (Jilin Provincial Drug Supervision and Administration Bureau) appeared on a ransomware extortion site and is being pressured to pay before any publication. If this is your organisation, or a supplier you depend on, the priority is to confirm the intrusion and contain it before the window to act closes.

  • Engage your incident-response team and preserve forensic evidence before remediating — do not wipe affected systems first.
  • Force a password reset and revoke active sessions for exposed accounts; rotate any credentials, API keys or certificates that may have been in the stolen data.
  • Assess regulatory notification duties (GDPR, NIS2, sector regulators) — many carry a 72-hour reporting clock from awareness.
  • Monitor for the data appearing on Pryx's leak site and across paste and breach channels, and brief downstream partners who may be exposed through you.

How we know this. Darkfield monitors public ransomware leak sites continuously, archiving every new disclosure and the data later released against the victim. Each entry on this page is sourced from the operator's own publication and cross-checked against complementary OSINT feeds (RansomLook, ransomware.live, RansomWatch). We do not collect or host stolen data — only the metadata, timestamps and screenshots needed to make the public disclosure searchable and accountable. Records here are corrected when the original post is edited, retracted, or merged with another disclosure.

吉林省药品监督管理局 (Jilin Provincial Drug Supervision and Administration Bureau) data breach — Pryx ransomware attack (2026) · Darkfield